Compagnie Lombard Odier SCmA’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $104K | Hold |
2,900
| – | – | ﹤0.01% | 283 |
|
|
2025
Q1 | $90.3K | Sell |
2,900
-5,800
| -67% | -$181K | ﹤0.01% | 312 |
|
|
2024
Q4 | $222K | Sell |
8,700
-5,300
| -38% | -$135K | ﹤0.01% | 234 |
|
|
2024
Q3 | $396K | Sell |
14,000
-3,000
| -18% | -$84.9K | 0.01% | 193 |
|
|
2024
Q2 | $448K | Hold |
17,000
| – | – | 0.01% | 189 |
|
|
2024
Q1 | $516K | Sell |
17,000
-3,000
| -15% | -$91.1K | 0.01% | 191 |
|
|
2023
Q4 | $562K | Sell |
20,000
-5,000
| -20% | -$140K | 0.01% | 210 |
|
|
2023
Q3 | $679K | Sell |
25,000
-5,000
| -17% | -$136K | 0.02% | 169 |
|
|
2023
Q2 | $922K | Sell |
30,000
-1,500
| -5% | -$46.1K | 0.03% | 142 |
|
|
2023
Q1 | $1.13M | Hold |
31,500
| – | – | 0.03% | 153 |
|
|
2022
Q4 | $1.25M | Hold |
31,500
| – | – | 0.03% | 147 |
|
|
2022
Q3 | $1.27M | Sell |
31,500
-1,000
| -3% | -$40.2K | 0.04% | 150 |
|
|
2022
Q2 | $1.37M | Hold |
32,500
| – | – | 0.03% | 138 |
|
|
2022
Q1 | $1.27M | Hold |
32,500
| – | – | 0.03% | 143 |
|
|
2021
Q4 | $1.3M | Sell |
32,500
-7,500
| -19% | -$299K | 0.03% | 160 |
|
|
2021
Q3 | $1.45M | Buy |
+40,000
| New | +$1.45M | 0.03% | 153 |
|